61 – 70 of 305
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease – Results from two independent population-based cohorts and a meta-analysis
(
- Contribution to journal › Article
-
Mark
Breaking barriers : a statistical and machine learning-based hybrid system for predicting dementia
(
- Contribution to journal › Article
-
Mark
Muscle mass, creatinine, cystatin C, and selective glomerular hypofiltration syndromes
2023) In Clinical Kidney Journal(
- Contribution to journal › Article
-
Mark
Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden
(
- Contribution to journal › Article
-
Mark
Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI) : a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
(
- Contribution to journal › Article
- 2022
-
Mark
Can frailty in conjunction with FRAX identify additional women at risk of fracture - a longitudinal cohort study of community dwelling older women
(
- Contribution to journal › Article
-
Mark
Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population
(
- Contribution to journal › Article
-
Mark
Bone Turnover Marker Profiling and Fracture Risk in Older Women : Fracture Risk from Age 75 to 90
(
- Contribution to journal › Article
-
Mark
Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
(
- Contribution to journal › Letter